Despite the growing threat of drug-resistant bacteria, few new antibiotics are reaching the market because of hurdles that biotech executives and experts say stand in the way.
The companies said the FDA, in an unusual step, requested they submit the clinical trial data they currently have while testing of a third dose in children under 5.
Part of the plan includes “optimizing” the workforce. Executives didn’t clarify whether that would include layoffs.
It’s a capital-efficient way to achieve growth without being pigeonholed into one strategy, and differs from the value-based blueprints of peers UnitedHealth and Humana.
While provider associations take the battle to court, private equity backed physician groups are absent from the litigation.
The combined organization — temporarily named BHSH System — will have a major presence in Michigan with 22 hospitals, a sizable outpatient business, a health plan covering 1 million people and a combined revenue of $13 billion.
A respite from treating large volumes of COVID-19 patients was short-lived last fall as people with symptoms filled hospital emergency rooms and boosted volumes in December, according to a new report.
Manufacturers, backed by professional bodies and lawmakers, have lined up on opposite sides of a debate about key aspects of the agency’s proposed rule that would create a new category of over-the-counter hearing aids.
The nonprofit has yet to publicly issue a comprehensive financial statement, but some initial figures illustrate how Cleveland Clinic — like some other major hospital chains — has actually prospered financially during the pandemic.
Payers are flagging concerns about changes to a CMS model aimed at encouraging more healthy consumers to sign up for insurance coverage, while new research finds the proposal could backfire.